No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Xifaxan is an antibiotic used to treat a variety of gastrointestinal infections, including traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. It is a rifaximin-based antibiotic, which is a semi-synthetic derivative of the natural antibiotic rifamycin. Xifaxan is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria. It is also well-tolerated, with few side effects.
Xifaxan is a relatively new antibiotic, having been approved by the FDA in 2004. It is used to treat a variety of gastrointestinal infections, including traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. It is also used to treat small intestinal bacterial overgrowth (SIBO).
The Xifaxan market is a growing one, with increasing demand for the drug due to its effectiveness and safety. It is a niche market, with few competitors. The main competitors are Merck, Allergan, and Salix Pharmaceuticals. Other companies in the market include Actavis, Lupin Pharmaceuticals, and Teva Pharmaceuticals. Show Less Read more
